BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 2, 2015
View Archived Issues
Dimension Therapeutics hemophilia gene therapy candidate receives FDA orphan designation
Read More
Fostamatinib wins U.S. orphan status for immune thrombocytopenic purpura
Read More
Sodium 2-hydroxylinoleate named U.S. orphan drug for neuroblastoma
Read More
FDA grants nivolumab orphan status for glioblastoma
Read More
Amgen reports development of aminopyridine PDE10A inhibitors
Read More
MicuRx's MRX-I shows comparable clinical cure rate to linezolid in phase II trial
Read More
Amicus Therapeutics to acquire Scioderm
Read More
Sun BioPharma to start phase I trial of SBP-101 in pancreatic ductal adenocarcinoma
Read More
Portage to advance PPL-003 to IND application for dry eye and uveitis
Read More
Study indicates that RAGE is a risk factor for developing heart failure
Read More
Juventas reports 1-year findings from phase II STOP-HF trial
Read More
Allergan completes acquisition of Naurex
Read More
FDA accepts Empliciti BLA for priority review
Read More
Trevena reports data from phase IIb study of TRV-130 in acute postoperative pain
Read More
Bristol-Myers Squibb reports HIV integrase inhibitors
Read More
Takeda discloses GPR6 modulators
Read More
Polyphor advances inhaled POL-6014 for lung diseases to phase I
Read More
Karus discloses PI3K inhibitors
Read More
CSIR divulges tricyclic antineoplastics
Read More
Celon Pharma discloses JAK-2 inhibitors
Read More
Merck & Co. discloses c-Met inhibitors
Read More
Encouraging results reported for Vaxart's oral influenza vaccine
Read More
Zecuity now available in the U.S.
Read More
Ring vaccination trial of Ebola virus vaccine VSV-EBOV extended to Sierra Leone
Read More
Strensiq launched in Japan for hypophosphatasia
Read More
FDA grants fast track designation to Flexion's FX-006 for knee osteoarthritis pain
Read More
Promising topline results from phase III STRUCTURE trial of romosozumab
Read More
FDA approves Augment Bone Graft
Read More